 Liposomal amphotericin drug-resistant visceral leishmaniasis treatment visceral leishmaniasis VL drug toxicity intolerance drug resistance Amphotericin AmB effective use toxicity renal impairment anaemia fever malaise hypokalaemia common Liposomes effective way drugs macrophages cells visceral leishmaniasis animals AmB liposomes effective experimental leishmaniasis low toxicity report successful treatment patient multiply drug-resistant visceral leishmaniasis prepared formulation liposomal amphotericin L-AmB Vestar San Dimas California USA comparison patient conventional AmB preliminary studies mice agents